Opinion section(s) | Recommendation |
---|---|
6.7 | Add studies on cigarette quit intentions and quit success |
6.5.3 | Add studies on the reduction in emissions of ENDS compared to cigarettes |
6.5.4 | Add biomarker studies showing ENDS exposures for users compared to cigarettes |
6.5.4 | Add studies on human health effects of ENDS substitution for cigarettes |
None | Add studies on population health effects and economic considerations |
3.2 6.5.4 6.6 | Discuss alternative hypotheses to gateway for explaining youth co-use of ENDS and tobacco products |
6.6 | Examine studies that contradict the gateway hypothesis |
6.6 6.7 | Show evidence of the longitudinal decline of cigarette use in EU member states |
6.5.1 | Show data demonstrating the stability in the prevalence rates of ENDS use by adults |
3.2 6.5.1 6.6 | Avoid citing ever-use data as a proxy or indicator for prevalence |
6.5.1 | Avoid citing past-30-day use as a proxy or indicator for regular use |
6.5.2 | Cite frequency of use data where available |
6.4 6.5.2 | Add data on non-nicotine use |
6.1 6.5.3 6.5.4 | Cite available studies and reviews with conflicting appraisals of cardiovascular risk |
3.2 6.5.4 6.6 | Contextualize the role of flavours in youth experimentation with the primary motivation of curiosity, and other factors such as vape tricks |
3.3 6.7 | Substantially enlarge the discussion of ENDS for cessation |